Introduction
============

Obstructive sleep apnea (OSA) is a highly prevalent disorder with considerable morbidity and mortality. Epidemiologic studies have linked OSA with cardiometabolic disorders as well as motor vehicle crashes. Studies have suggested up to a sevenfold increase in crashes in patients with OSA.[@b1-nss-6-065] OSA prevalence is likely rising due to the aging of the population and the obesity epidemic. Moreover, the prevalence of OSA among high-risk occupations, such as commercial drivers, is thought to be even higher than in the general population.[@b2-nss-6-065],[@b3-nss-6-065] Microarousals and oxygen desaturation among patients with OSA have been linked to excessive daytime sleepiness and decreases in attention contributing to motor vehicle crash risk.[@b4-nss-6-065] However, the lack of clinical or polysomnographic characteristics that identify patients at higher risk of crash makes it difficult for clinicians to predict which OSA patients should be prioritized for therapy and when they should be restricted from complex safety sensitive tasks such as driving. The situation is especially difficult among commercial drivers, who either are unaware or minimize their impairment. Additionally, there is only a weak correlation between sleep apnea severity or oxygen desaturation and the risk for motor vehicle crash.[@b5-nss-6-065] Currently, commercial driver medical examinations rely primarily on subjective self-reports of sleepiness and other symptoms despite their being notoriously unreliable. Thus, the identification of objective measures of sleepiness and vigilance in OSA patients is critical to identify which patients may be at higher risk of complications.

Vigilance, a state of heightened readiness to perform efficiently, is thought to be impaired in patients with sleep apnea.[@b6-nss-6-065],[@b7-nss-6-065] The psychomotor vigilance task (PVT) is sensitive to sleep deprivation and is widely used as an objective tool to identify cognitive impairment in a variety of situations, such as sleep restriction, napping, and sleepiness.[@b6-nss-6-065]--[@b8-nss-6-065] In an attempt to identify clinical parameters associated with vigilance in OSA patients at potential risk for motor vehicle crash, we conducted a cross-sectional study of PVT performance in a sleep clinic-derived OSA population.

We hypothesized that greater daytime sleepiness in patients with untreated sleep apnea would be associated with worse performance on PVT. Ultimately, our goal would be to develop simple, objective tools in occupational clinics to identify persons at higher risk for impairment during safety sensitive tasks such as driving.

Materials and methods
=====================

Between January 2011 and December 2011, all eligible patients (≥18 years of age) referred to our sleep clinics for evaluation of possible sleep apnea were approached for this study when a research technician was available. A total of 100 subjects consented. Exclusion criteria were 1) use of stimulants (eg, amphetamines, modafinil), 2) known head injury, 3) dementia or retardation, 4) alcohol or drug abuse, and 5) pregnancy. Prior to participation, all subjects provided written informed consent. The study protocol was approved by the Partners' Institutional Review Board of the Brigham and Women's hospital.

Sleep evaluation
----------------

The subjects underwent either a standard clinical overnight in-laboratory polysomnography (electroencephalogram, electrooculogram, chin and anterior tibial electromyogram, electrocardiogram, airflow using nasal pressure and oronasal thermistor, respiratory excursions using inductance plethysmography, and pulse oximetry) or a home sleep study. Respiratory events were scored blindly using Chicago criteria[@b9-nss-6-065] (hypopneas were defined as a \>50% reduction in airflow from the baseline value lasting \>10 seconds and associated with a 3% desaturation or arousal. Apneas were defined as the absence of airflow lasting \>10 seconds). Apnea hypopnea index (AHI) was defined as the number of apneas and hypopneas per hour of sleep. The severity of sleep apnea was ranked as mild, moderate, or severe based on AHI categories (5-\<15, 15--30, and \>30).

Sleep quality was assessed using the Pittsburgh sleep quality index (PSQI). The PSQI is a commonly used and validated instrument that provides a self-assessed measure of sleep disturbance and sleep quality over the preceding month. Nineteen items provide ratings on subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction.[@b10-nss-6-065]

Clinical characteristics including body mass index (BMI) and neck circumference were measured by an experienced medical assistant naïve to the goals of the research study.

Daytime sleepiness evaluation
-----------------------------

All participants were evaluated for daytime sleepiness and vigilance using the Epworth sleepiness scale (ESS) and PVT, respectively. The subjects completed the questionnaire and performed PVT on the same day.

### Epworth sleepiness scale

The ESS is a simple self-administered test and is used frequently to measure the subjective level of daytime sleepiness.[@b11-nss-6-065] It consists of eight items regarding the likelihood of dozing in sedentary situations that patients rate on a Likert scale. The simple questionnaire has been validated in previous studies, and a significant correlation was found between ESS scores and those of mean sleep latency tests (*r*= −0.5, *P*\<0.01). The ESS questionnaire was administered as part of the initial sleep clinic evaluation.

### Psychomotor vigilance task

PVT has been demonstrated to be sensitive to sleep disruption and is regarded as an objective measure of vigilance in a variety of experimental conditions.[@b6-nss-6-065]--[@b8-nss-6-065] The current study utilized a portable device (Model PVT-192; CWE, Inc., Ardmore, PA, USA) based on the original test described in 1985 by Dinges and Powel[@b12-nss-6-065] (microcomputer analysis). The participants sat in a closed and quiet examination room, without any auditory or visual disturbance. A 1-minute mock PVT demonstration was done prior to each test. The PVT visual display was held 14--22 inches from the subject's eyes. The participants were asked to either use the index finger or thumb of their dominant hand to respond to the PVT signals. The participants were instructed to maintain the fastest possible reaction times to a simple visual stimulus: a red light-emitting diode displaying time in milliseconds in a window of the portable PVT device. Each PVT administration lasted 10 minutes, during which the stimuli randomly appeared at variable intervals of 2--10 seconds.

Based on previous research on PVT, we included the following outcome measures of PVT performance: 1) mean reaction time (RT), 2) mean I/RT (reciprocal response time or response speed), 3) slowest 10% I/RT, 4) fastest 10% of RT, and 5) number of lapses, defined as RT \>500 milliseconds (errors of omission). Responses were considered valid if the RT was \>100 milliseconds. Responses without a stimulus or RT \<100 milliseconds were counted as false starts (errors of commission).

Statistical analysis
--------------------

Statistical analysis was performed using Stata software, version 11 (StataCorp, College Station, TX, USA). Univariate and multivariate logistic regression models were used to assess the ability of hypothesized variables to predict lack of attention or poor performance. The distributions were examined graphically, and non-normally distributed variables were natural log or square root transformed. In the multiple regression analysis, we examined the association between PVT performance and the following: OSA severity as measured by AHI, sleepiness as assessed by ESS, age, BMI, sex, and PSQI global score. Statistical significance was set at a *P*-value\<0.05, two-tailed.

Results
=======

[Table 1](#t1-nss-6-065){ref-type="table"} demonstrates the clinical and anthropometric parameters among the participants stratified according to AHI categories. Mean age of the participants was 46±15 years. The majority of the participants in the higher AHI category (\>30/hour) were male and obese (median BMI was 37 kg/m^2^ with 25% and 75% being 33 kg/m^2^ and 42 kg/m^2^, respectively). Similar trends were noted after stratification by ESS categories ([Table 2](#t2-nss-6-065){ref-type="table"}). The mean PSQI global score for the cohort was 7.9, suggesting poor sleep prior to testing.

PVT performance variables according to AHI category are shown in [Table 3](#t3-nss-6-065){ref-type="table"}. Participants in the AHI category 15--30/hour had prolonged mean reaction times; however, this observation was not statistically significant. In contrast, significantly worse PVT performance was noted among participants who reported high ESS scores (*P*=0.04) ([Table 4](#t4-nss-6-065){ref-type="table"}). The mean of the slowest 10% of RT was prolonged among participants with ESS score \>9 (*P*\<0.05). In the univariate regression model ([Table 5](#t5-nss-6-065){ref-type="table"}), a statistically significant association was observed between age and various PVT variables. In the same model, higher BMI, AHI, ESS, and PSQI were significantly associated with poorer performance on PVT. In addition, a marginally significant association was noted among ESS and PVT lapses (*P*=0.05). [Table 6](#t6-nss-6-065){ref-type="table"} presents the results of multivariable regression analysis of PVT variables adjusting for age, BMI, AHI, ESS, PSQI score, and sex. In this model, age was significantly related to poor performance on all of the PVT variables (*P*\<0.05). Similarly, a significant association was found between slowest 10% RT, lapses, and BMI (*P*\<0.05). In addition, poor PVT performance was also noted among participants with poor sleep quality as measured by PSQI. However, a marginally significant association was found between ESS and PVT variables in this model. Subgroup univariate analysis suggested that compared to men, women had significantly worse performance on all PVT measures (*P*\<0.05) (data not shown). However, adding sex to the full multiregression model did not change the results.

Discussion
==========

The current study sought to identify clinical parameters associated with vigilance in a sleep clinic-derived OSA population. The main findings of this cross-sectional study were that poor sleep quality as measured by PSQI score, and subjective sleepiness as measured by the ESS, were associated with poor PVT performance, while OSA severity as categorized by AHI was not associated with variation in PVT measures. The findings of this study are consistent with previous literature demonstrating an association between lack of sleep and poor PVT performance.[@b13-nss-6-065],[@b14-nss-6-065] Studies have also demonstrated weak but significant correlations between the ESS and the risk of motor vehicle accident.[@b4-nss-6-065],[@b15-nss-6-065] A twofold increase in the risk of accidents among drivers with sleepiness as measured by ESS has also been reported in another study by Howard et al.[@b3-nss-6-065] Similarly, elevated ESS scores were found among drivers with crashes.[@b16-nss-6-065]

Although ESS has been shown to have an association with motor vehicle crashes, studies have reported that many patients do not subjectively report impaired vigilance.[@b17-nss-6-065],[@b18-nss-6-065] In particular, self-reported questionnaires are not reliable in assessing the degree of sleepiness, particularly in occupational settings.[@b19-nss-6-065] Parks et al demonstrated that among commercial drivers at high-risk for OSA, 85% denied snoring or daytime sleepiness[@b20-nss-6-065] when asked during medical certification examinations for driving. Thus, PVT may have diagnostic utility as an objective tool, particularly in settings where subjective reporting may be unreliable.

The current study did not find any significant association between OSA severity as measured by AHI and vigilance-related PVT performance. These results are consistent with previously published studies where OSA severity was found to be unrelated to the PVT performance.[@b7-nss-6-065],[@b21-nss-6-065] While OSA has been shown to increase the risk of accidents, it is not clear which OSA patients are at increased risk. Gozal et al have suggested differential susceptibility to the impact of sleep disturbance, perhaps on a genetic basis.[@b22-nss-6-065] The cutoff levels of severity for AHI are arbitrary and have been a source of controversy. Moreover, it has been suggested that there is only weak correlation between the AHI and the risk of motor vehicle crash,[@b5-nss-6-065] as these rare events are likely multifactorial and thus hard to predict. In addition, treatment of sleep-disordered breathing has been shown to reduce the risk of accidents.[@b23-nss-6-065] Thus, considering the risks and costs associated with motor vehicle crashes related to sleep-disordered breathing, it is crucial to identify OSA patients with impaired vigilance and enforce treatment of high-risk patients. This goal is of particular importance for commercial drivers and those involved in safety sensitive jobs.

Our study extends the results of previously published studies demonstrating decrements in PVT performance with high BMI.[@b7-nss-6-065],[@b24-nss-6-065],[@b25-nss-6-065] Obesity has also been shown to increase the risk of motor vehicle crashes.[@b26-nss-6-065],[@b27-nss-6-065] It has been proposed that obese patients have difficulty moving easily in the driver's seat, leading to reduced ability to see traffic approaching from the back or side.[@b26-nss-6-065] More importantly, increases in the level of inflammatory mediators within adipose tissues have been shown to reduce vigilance and increase sleepiness.[@b28-nss-6-065]

Finally, our study suggests that the magnitude of PVT impairment varies with sex, confirming previously published results.[@b29-nss-6-065] We found statistically significant differences in PVT performance, with poor performance among women. The reasons for this sex difference are not clear, but perhaps reflect increased experience with electronic media such as video games among males over females.

Despite our study's strengths, we acknowledge a number of limitations. First, we did not have a healthy control group since the subjects were all enrolled in a sleep clinic. As such, the performance on PVT may be better in nonclinical populations. However, because our goal was to define a method of defining risk among potentially susceptible clinic patients, we believe we have made the relevant comparisons in the present study. However, we acknowledge that we cannot address whether clinical OSA patients perform better or worse than healthy controls from the community. Second, our cross-sectional design and our sample size did not allow us to assess prospectively risk of subsequent motor vehicle accidents, which are fairly rare events. Thus, we cannot draw any rigorous conclusions about whether we can actually predict accidents or not. Moreover, our study was not performed in commercial drivers although such a study is ongoing with our collaborators. Third, our study was cross-sectional, and thus we did not assess response to therapy. Thus, we do not have data regarding the reversibility of the observed abnormalities. Finally, lack of strong association between ESS and PVT variables in the multiple regression model could be related to small sample size or also that higher ESS is associated with increasing BMI and age, and therefore, was no longer significant when these factors were considered together, underscoring the need for an objective tool to assess daytime sleepiness.

Despite these limitations, we believe our paper adds importantly to the existing literature and is worth pursuing in further research.

In summary, psychomotor vigilance testing performance is associated with sleepiness as measured by ESS, and therefore may be of value as a risk assessment tool in populations where subjective reports are unreliable.
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###### 

Baseline characteristics of study participants according to apnea hypopnea index categories

  Variables                                                                              Apnea hypopnea index                                   
  -------------------------------------------------------------------------------------- ---------------------- --------------- --------------- ---------------
  Age years, mean (SD)                                                                   42.9 (15.5)            52.0 (14.6)     47.0 (10.9)     52.0 (16.9)
  Males, n (%)                                                                           9 (50)                 11 (58)         7 (70)          11 (79)
  BMI kg/m^2^, median (Q1, Q3)[\*](#tfn1-nss-6-065){ref-type="table-fn"}                 32.0 (27, 39)          31.5 (26, 35)   32.6 (31, 36)   37.0 (33, 42)
  ESS, mean (SD)                                                                         10 (4)                 8.9 (6.5)       11.9 (6.1)      12.1 (5.6)
  Neck circumference inches, median (Q1, Q3)[\*](#tfn1-nss-6-065){ref-type="table-fn"}   15 (14, 17)            16 (14, 17)     16 (15, 18)     18 (17, 20)
  Hypertension, n (%)                                                                    7 (39)                 7 (41)          2 (20)          10 (71)
  PSQI score, mean (SD)                                                                  8.2 (3.0)              8.8 (4.4)       6.8 (2.5)       8.1 (5.5)

**Note:**

Represents quartile 1 and 3.

**Abbreviations:** BMI, body mass index; ESS, Epworth sleepiness scale; PSQI, Pittsburgh sleep quality index; SD, standard deviation.

###### 

Baseline characteristics of study participants according to Epworth sleepiness scale categories

  ------------------------------------------------------------------------------------------------------------------------------
                                                                                         ESS ≤9\             ESS \>9\
                                                                                         n=25                n=36
  -------------------------------------------------------------------------------------- ------------------- -------------------
  Age years, mean (SD)                                                                   46.6 (17.5)         49.9 (13)

  Males, n (%)                                                                           16 (64)             22 (61)

  BMI kg/m^2^, median (Q1, Q3)[\*](#tfn3-nss-6-065){ref-type="table-fn"}                 32.3 (29.0, 39.2)   33.2 (27.0, 38.0)

  AHI, median (Q1, Q3)[\*](#tfn3-nss-6-065){ref-type="table-fn"}                         9 (5, 23)           13 (4, 29)

  Neck circumference inches, median (Q1, Q3)[\*](#tfn3-nss-6-065){ref-type="table-fn"}   16.0 (14.5, 17.5)   16.0 (15.0, 18.0)

  Hypertension, n (%)                                                                    9 (37.5)            17 (48.6)

  PSQI score, mean (SD)                                                                  8.1 (4.2)           8.2 (3.9)
  ------------------------------------------------------------------------------------------------------------------------------

**Note:**

Represents quartile 1 and 3.

**Abbreviations:** AHI, apnea hypopnea index; BMI, body mass index; ESS, Epworth sleepiness scale; PSQI, Pittsburgh sleep quality index; SD, standard deviation.

###### 

Psychomotor vigilance task performance by the apnea hypopnea index categories

  PVT variables                                                           AHI categories   *P*-value                                
  ----------------------------------------------------------------------- ---------------- ------------- ------------ ------------- ------
  RT (ms)[\*](#tfn5-nss-6-065){ref-type="table-fn"}                       283 (37)         265 (47)      286 (49)     265 (34)      0.37
  Fastest 10% RT (ms)[\*](#tfn5-nss-6-065){ref-type="table-fn"}           209 (21)         194 (25)      209 (24)     200 (23)      0.18
  Slowest 10% RT (ms)[\*](#tfn5-nss-6-065){ref-type="table-fn"}           451 (164)        453 (182)     492 (184)    407 (88)      0.64
  I/slowest 10% RT (ms)[\*](#tfn5-nss-6-065){ref-type="table-fn"}         2.5 (0.45)       2.6 (0.61)    2.4 (0.69)   2.6 (0.41)    0.70
  I/RT (ms)[\*](#tfn5-nss-6-065){ref-type="table-fn"}                     3.7 (0.42)       4.1 (0.59)    3.8 (0.54)   3.9 (0.42)    0.17
  Lapses (RT \>500 ms)[\*\*](#tfn6-nss-6-065){ref-type="table-fn"}        0.9 (0.92)       0.97 (0.91)   1.4 (1.1)    0.68 (0.81)   0.34
  False start (RT \<100 ms)[\*\*](#tfn6-nss-6-065){ref-type="table-fn"}   0.9 (1.3)        0.93 (1.0)    0.59 (1.0)   1.3 (1.1)     0.48

**Notes:**

Log transformed;

square root transformed; PVT variables represent back transformation after log/square root transformation. All PVT variable data is presented as mean (SD).

**Abbreviations:** AHI, apnea hypopnea index; I/RT, reciprocal response time; I/slowest, reciprocal of slowest response time; ms, milliseconds; PVT, psychomotor vigilance task; RT, reaction time; SD, standard deviation.

###### 

Psychomotor vigilance task performance by Epworth sleepiness score categories

  PVT variables                                                           ESS categories   *P*-value    
  ----------------------------------------------------------------------- ---------------- ------------ ----------
  RT (ms)[\*](#tfn8-nss-6-065){ref-type="table-fn"}                       260 (27)         283.4 (48)   **0.04**
  Fastest 10% RT (ms)[\*](#tfn8-nss-6-065){ref-type="table-fn"}           198 (20)         204 (25)     0.27
  Slowest 10% RT (ms)[\*](#tfn8-nss-6-065){ref-type="table-fn"}           396 (100)        485 (181)    **0.03**
  I/slowest 10% RT (ms)[\*](#tfn8-nss-6-065){ref-type="table-fn"}         2.8 (0.42)       2.4 (0.57)   **0.01**
  I/RT (ms)[\*](#tfn8-nss-6-065){ref-type="table-fn"}                     4.03 (0.41)      3.8 (0.55)   0.11
  Lapses (RT \>500 ms)[\*\*](#tfn9-nss-6-065){ref-type="table-fn"}        0.6 (0.73)       1.2 (1.0)    **0.03**
  False start (RT \<100 ms)[\*\*](#tfn9-nss-6-065){ref-type="table-fn"}   0.86 (1.1)       1 (1.1)      0.62

**Notes:**

Log transformed;

square root transformed; PVT variables represent back transformation after log/square root transformation; Bold *P*-values represent statistical significance. All PVT variable data is presented as mean (SD).

**Abbreviations:** ESS, Epworth sleepiness scale; I/RT, reciprocal response time; I/slowest, reciprocal of slowest response time; ms, milliseconds; PVT, psychomotor vigilance task; RT, reaction time; SD, standard deviation.

###### 

Univariate regression models predicting psychomotor vigilance task variables

                                                                            Age (years)           BMI (kg/m^2^)         ESS               PSQI               Arousal index     AHI (events/hour)
  ------------------------------------------------------------------------- --------------------- --------------------- ----------------- ------------------ ----------------- -------------------
  RT[\*](#tfn11-nss-6-065){ref-type="table-fn"} (ms)                        0.13 **(0.001)**      0.03 (0.12)           0.04 (0.16)       0.11 (**0.01)**    0.04 **(0.03)**   0.02 **(0.03)**
  I/RT[\*](#tfn11-nss-6-065){ref-type="table-fn"} (ms)                      0.09 **(0.015)**      0.01 (0.35)           0.03 (0.24)       0.14 **(0.003)**   0.04 **(0.05)**   0.02 **(0.05)**
  Fastest 10% RT[\*](#tfn11-nss-6-065){ref-type="table-fn"} (ms)            0.05 (0.09)           0.004 (0.61)          0.009 (0.47)      0.11 **(0.009)**   0.02 (0.11)       0.03 **(0.04)**
  Slowest 10% RT[\*](#tfn11-nss-6-065){ref-type="table-fn"} (ms)            0.18 (\<**0.001)**    0.09 **(0.005)**      0.06 (0.07)       0.03 (0.25)        0.03 (0.19)       0.01 (0.12)
  I/slowest 10% RT[\*](#tfn11-nss-6-065){ref-type="table-fn"} (ms)          0.15 (\<**0.0001)**   0.08 **(0.01)**       0.07 (0.07)       0.07 (0.06)        0.04 **(0.02)**   0.01 (0.17)
  Lapses[\*\*](#tfn12-nss-6-065){ref-type="table-fn"} (RT \>500 ms)         0.15 (\<**0.0001)**   0.16 (\<**0.0001)**   0.07 **(0.05)**   0.01 (0.4)         0.003 (0.7)       0.007 (0.34)
  False starts[\*\*](#tfn12-nss-6-065){ref-type="table-fn"} (RT \<100 ms)   0.08 (0.03)           0.02 (0.23)           0.001 (0.9)       0.001 (0.9)        0.01 (0.6)        0.01 (0.6)

**Notes:**

Log transformed;

square root transformed; Bold *P*-values represent statistical significance.

**Abbreviations:** AHI, apnea hypopnea index; BMI, body mass index; ESS, Epworth sleepiness scale; I/RT, reciprocal response time; I/slowest, reciprocal of slowest response time; ms, milliseconds; PSQI, Pittsburgh sleep quality index (global) score; RT, reaction time; SD, standard deviation.

###### 

Multiple regression model

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                      Age (years)                  BMI (kg/m^2^)             ESS                       PSQI                       AHI (events/hour)         Sex
  ------------------------------------------------------------------- ---------------------------- ------------------------- ------------------------- -------------------------- ------------------------- -----------------------
  RT[\*](#tfn14-nss-6-065){ref-type="table-fn"} (ms)                  −0.003 (−0.01 to --0.002)\   0.001 (−0.004--0.004)     0.005 (−0.001--0.01)      0.01 (0.0003--0.02)\       −0.0005 (−0.0002--0.02)   --0.05 (−0.14--0.02)
                                                                      **0.01**                                                                         **0.055**                                            

  Slowest 10% RT[\*](#tfn14-nss-6-065){ref-type="table-fn"} (ms)      0.007 (−0.01--0.01)\         −0.01 (−0.01--0.001)      −0.01 (−0.1 to −0.01)\    0.01 (−0.01--0.03)         0.0005 (−0.002--0.001)    0.06 (0.21--0.09)
                                                                      **0.005**                                              **0.06**                                                                       

  1/RT[\*](#tfn14-nss-6-065){ref-type="table-fn"} (ms)                −0.002 (−0.004--0.0001)\     −0.001 (−0.005--0.003)    −0.004 (−0.01--0.002)     −0.01 (−0.02 to −0.002)\   0.0004 (−0.0004--0.001)   0.06 (−0.01 to −0.13)
                                                                      **0.045**                                                                        **0.03**                                             

  Lapses[\*\*](#tfn15-nss-6-065){ref-type="table-fn"} (RT \>500 ms)   0.02 (0.01--0.03)\           −0.04 (−0.07 to −0.01)\   0.04 (−0.003 to −0.08)\   0.01 (−0.05--0.07)         0.001 (−0.007--0.01)      0.12 (0.68--0.43)
                                                                      **0.008**                    **0.006**                 **0.07**                                                                       
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:**

Log transformed;

square root transformed; Bold *P*-values represent statistical significance.

**Abbreviations:** AHI, apnea hypopnea index; BMI, body mass index; ESS, Epworth sleepiness scale; I/RT, reciprocal response time; ms, milliseconds; PSQI, Pittsburgh sleep quality index (global) score; RT, reaction time.
